PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,793,035 | +44.8% | 943,491 | +47.6% | 0.00% | 0.0% |
| Q2 2023 | $4,000,421 | +28.3% | 639,045 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $3,117,820 | -41.1% | 653,631 | +7.5% | 0.00% | 0.0% |
| Q4 2022 | $5,289,165 | -15.6% | 607,950 | +15.5% | 0.00% | 0.0% |
| Q3 2022 | $6,265,000 | -7.8% | 526,464 | +10.4% | 0.00% | -50.0% |
| Q2 2022 | $6,796,000 | -21.9% | 476,934 | +14.1% | 0.00% | 0.0% |
| Q1 2022 | $8,703,000 | +51.1% | 418,045 | +67.7% | 0.00% | +100.0% |
| Q4 2021 | $5,758,000 | -34.2% | 249,242 | -15.2% | 0.00% | -50.0% |
| Q3 2021 | $8,756,000 | +65.0% | 293,840 | +89.1% | 0.00% | +100.0% |
| Q2 2021 | $5,307,000 | +99.6% | 155,377 | +92.2% | 0.00% | 0.0% |
| Q1 2021 | $2,659,000 | -55.3% | 80,861 | -51.8% | 0.00% | -50.0% |
| Q3 2020 | $5,955,000 | – | 167,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |